Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Design of a Multi-Epitope Peptide Vaccine Against Glioblastoma Multiforme Targeting Il13rα2 and Epha2: An Immuno-Informatics Approach; [یحارطکینسکاودیتپپیپادنچیپوتیهیلعیاموتسالبویلگیلکشدنچابیریگفدههدنریگدحاوریز۲افلآ ۱۳-نیکولرتنیاوهدنریگنیرفاعون:A2درکیورمیان-ییتابساحم] Publisher

Summary: Could a peptide vaccine target glioblastoma? Computer simulations of IL13Rα2 and EPHA2 epitopes suggest immune potential and TLR3 binding; lab testing is still needed. #BrainCancer #Vaccines

Ahangarzadeh S ; Rahimmanesh I
Authors

Source: Journal of Isfahan Medical School Published:2026


Abstract

Background: Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor and is highly resistant to conventional therapies. Designing multi-epitope peptide vaccines represents a promising strategy to elicit tumor antigen-specific immune responses. Methods: Using immunoinformatics tools, cytotoxic T lymphocyte (CTL) and B-cell epitopes were identified from the IL13Rα2 and EPHA2 tumor-associated antigens and filtered based on antigenicity, non-allergenicity, and non-toxicity. The final vaccine construct comprised 16 CTL epitopes and 6 B-cell epitopes. Physicochemical properties, structural features, and interactions of the vaccine with Toll-like receptors (TLRs) were evaluated. Findings: The final vaccine consisted of 281 amino acids, with a molecular weight of 31,579.57 Da, pI = 8.98, and an instability index of 26.10, indicating high stability. A GRAVY value of −0.463 and a QuerySol score of 0.539 suggested favorable hydrophilicity and solubility. The refined 3D structure showed 93.6% of residues in favored regions of the Ramachandran plot, and a Z-score of −1.63 confirmed good structural quality. Molecular docking analyses revealed the strongest binding affinity toward TLR3 (ΔG = −11.1 kcal/mol; Kd ≈ 1.6×10⁻⁸ M). Immune simulation demonstrated robust induction of both humoral and cellular immune responses: rapid IgM production after the first immunization followed by isotype switching to IgG1/IgG2 in subsequent doses. In silico immune simulation with C-ImmSim suggested a potential for robust induction of both humoral and cellular immune responses. Conclusion: The designed multi-epitope vaccine exhibits favorable immunogenicity, stability, and strong interaction with TLR3, positioning it as a promising candidate for further preclinical development as a therapeutic vaccine against glioblastoma. © 2026, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Development of a Chimeric Vaccine Candidate Based on Toxoplasma Gondii Major Surface Antigen 1 and Apicoplast Proteins Using Comprehensive Immunoinformatics Approaches, European Journal of Pharmaceutical Sciences (2021)
2. In Silico Analysis of Transmembrane Protein 31 (Tmem31)Antigen to Design Novel Multiepitope Peptide and Dna Cancer Vaccines Against Melanoma, Molecular Immunology (2019)
3. Engineering a Multi-Epitope Vaccine Candidate Against Leishmania Infantum Using Comprehensive Immunoinformatics Methods, Biologia (2022)
Experts (# of related papers)
View all Related Experts
Peyman Bemani (4)
Shahrzad Ahangarzadeh (2)
Design of a Multi-Epitope Peptide Vaccine Against Glioblastoma Multiforme Targeting Il13rα2 and Epha2: An Immuno-Informatics Approach; [یحارطکینسکاودیتپپیپادنچیپوتیهیلعیاموتسالبویلگیلکشدنچابیریگفدههدنریگدحاوریز۲افلآ ۱۳-نیکولرتنیاوهدنریگنیرفاعون:A2درکیورمیان-ییتابساحم]
Other Related Docs
4. Immunoinformatic Approach to the Design of a Novel Multi-Epitope Vaccine Against Leishmania Major Fused to Human Igg-Fc, Research in Pharmaceutical Sciences (2024)
5. Design of a Multi-Epitope Vaccine Against Staphylococcus Aureus Lukotoxin Ed Using in Silico Approaches, Scientific Reports (2025)
6. Design of Multivalent-Epitope Vaccine Models Directed Toward the World’S Population Against Hiv-Gag Polyprotein: Reverse Vaccinology and Immunoinformatics, PLoS ONE (2024)
7. Bioinformatics Design of a Peptide Vaccine Containing Sarcoma Antigen Ny-Sar-35 Epitopes Against Breast Cancer and Evaluation of Its Immunological Function in Balb/C Mouse Model, PLoS ONE (2024)
8. Exploring the Cancer-Testis Antigen Boris to Design a Novel Multi-Epitope Vaccine Against Breast Cancer Based on Immunoinformatics Approaches, Journal of Biomolecular Structure and Dynamics (2022)
9. Designing and Characterization of Tregitope-Based Multi-Epitope Vaccine Against Multiple Sclerosis: An Immunoinformatic Approach, Current Drug Safety (2023)
10. Development of Polyepitopic Immunogenic Contrast Against Hepatitis C Virus 1A-6A Genotype by in Silico Approach, Biomedical and Biotechnology Research Journal (2020)
11. Insights Into the Biochemical Features and Immunogenic Epitopes of Common Bradyzoite Markers of the Ubiquitous Toxoplasma Gondii, Infection, Genetics and Evolution (2021)
12. Bioinformatics Analysis for the Purpose of Designing a Novel Multi-Epitope Dna Vaccine Against Leishmania Major, Scientific Reports (2022)
13. In Silico Design of Discontinuous Peptides Representative of B and T-Cell Epitopes From Her2-Ecd As Potential Novel Cancer Peptide Vaccines, Asian Pacific Journal of Cancer Prevention (2013)
14. Sars-Cov-2 Variant-Specific Mrna Vaccine: Pros and Cons, Viral Immunology (2023)
15. Immunoinformatics Design and Synthesis of a Multi-Epitope Vaccine Against Helicobacter Pylori Based on Lipid Nanoparticles, Scientific Reports (2024)
16. Immunoprotective Effect of an in Silico Designed Multiepitope Cancer Vaccine With Boris Cancer-Testis Antigen Target in a Murine Mammary Carcinoma Model, Scientific Reports (2021)
17. In-Silico Design of a New Multi-Epitope Vaccine Candidate Against Sars-Cov-2, Acta Virologica (2023)
18. Designing a Chimeric Subunit Vaccine for Influenza Virus, Based on Ha2, M2e and Ctxb: A Bioinformatics Study, BMC Molecular and Cell Biology (2020)
19. Production, Purification, and in Vivo Evaluation of a Novel Multiepitope Peptide Vaccine Consisted of Immunodominant Epitopes of Sycp1 and Acrbp Antigens As a Prophylactic Melanoma Vaccine, International Immunopharmacology (2019)
20. Designing a Multi-Epitope Vaccine Against Notch1 and Notch4: A Computational Approach for Triple-Negative Breast Cancer, BioMed Research International (2026)